INS and Insulin resistance: Given that pioglitazone is insulin-sensitizing and iron overload has been shown to result in insulin resistance in the heart [24], pioglitazone’s interaction with MitoNEET and potential involvement in mitochondrial iron regulation may be a basis of part of its therapeutic impact.